自身免疫性疾病:分子病原和治疗点
Xiaoshuang Song1,2, Hantian Liang1, Fang Nan1
1Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy West China Hospital Sichuan University Chengdu Sichuan China.
MedComm
|June 18, 2025
概括
自免疫性疾病发生在免疫系统攻击身体时,导致炎症和损伤. 本综述涵盖了它们的原因,诊断和治疗方法,包括新的精准医学方法.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 药理学 药理学 是一个学科.
背景情况:
- 自身免疫性疾病影响全球10%的人口,导致慢性炎症和全身功能障碍.
- 病原发生涉及遗传倾向,环境触发因素和免疫失调.
- 这些情况给全球健康和经济带来了重大挑战.
研究的目的:
- 提供常见的自身免疫性疾病的全面概述.
- 详细介绍临床表现,致病机制和诊断方法.
- 探索当前和新兴的治疗策略.
主要方法:
- 临床前和临床研究的文献综述.
- 综合有关疾病病原和临床表型的信息.
- 对诊断方法的分析,包括自身抗体.
主要成果:
- 详细概述了自身免疫性疾病的特征.
- 广泛的抗炎药物的探索.
- 讨论分子向疗法 (例如,JAK抑制剂,单克隆抗体) 和细胞疗法 (例如,CAR T细胞,Treg疗法).
结论:
- 综合了当前对自身免疫性疾病的理解.
- 该审查将基础科学与临床实践联系起来.
- 突出了针对自身免疫性疾病的精密医学的未来进展.
相关概念视频
Autoimmune Disorders
685
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
685
What is the Immune System?
117.5K
Overview
117.5K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Antigens Involved in Adaptive Immunity
704
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
704


